Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sherif Bayoumy, Inge M. W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M. van der Flier, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L. Dage, Charlotte E. Teunissen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a80f98ef3db432c84a8599a0bf54390
record_format dspace
spelling oai:doaj.org-article:9a80f98ef3db432c84a8599a0bf543902021-12-05T12:24:30ZClinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau23110.1186/s13195-021-00939-91758-9193https://doaj.org/article/9a80f98ef3db432c84a8599a0bf543902021-12-01T00:00:00Zhttps://doi.org/10.1186/s13195-021-00939-9https://doaj.org/toc/1758-9193Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lilly), and two P-tau231 (ADx, Gothenburg). Methods We studied the analytical (sensitivity, precision, parallelism, dilution linearity, and recovery) and clinical (40 AD dementia patients, age 66±8years, 50%F; 40 age- and sex-matched controls) performance of the assays. Results All assays showed robust analytical performance, and particularly P-tau217 Eli Lilly; P-tau231 Gothenburg and all P-tau181 assays showed robust clinical performance to differentiate AD from controls, with AUCs 0.936–0.995 (P-tau231 ADx: AUC = 0.719). Results obtained with all P-tau181 assays, P-tau217 Eli Lilly assay, and P-tau231 Gothenburg assay strongly correlated (Spearman’s rho > 0.86), while correlations with P-tau231 ADx results were moderate (rho < 0.65). Discussion P-tau isoforms can be measured robustly by several novel high-sensitive Simoa assays.Sherif BayoumyInge M. W. VerberkBen den DulkZulaiga HussainaliMarissa ZwanWiesje M. van der FlierNicholas J. AshtonHenrik ZetterbergKaj BlennowJeroen VanbrabantErik StoopsEugeen VanmechelenJeffrey L. DageCharlotte E. TeunissenBMCarticleAlzheimer’s diseaseBlood biomarkersP-tau181P-tau217P-tau231Phosphorylated tau proteinsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENAlzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
Blood biomarkers
P-tau181
P-tau217
P-tau231
Phosphorylated tau proteins
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Alzheimer’s disease
Blood biomarkers
P-tau181
P-tau217
P-tau231
Phosphorylated tau proteins
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Sherif Bayoumy
Inge M. W. Verberk
Ben den Dulk
Zulaiga Hussainali
Marissa Zwan
Wiesje M. van der Flier
Nicholas J. Ashton
Henrik Zetterberg
Kaj Blennow
Jeroen Vanbrabant
Erik Stoops
Eugeen Vanmechelen
Jeffrey L. Dage
Charlotte E. Teunissen
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
description Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lilly), and two P-tau231 (ADx, Gothenburg). Methods We studied the analytical (sensitivity, precision, parallelism, dilution linearity, and recovery) and clinical (40 AD dementia patients, age 66±8years, 50%F; 40 age- and sex-matched controls) performance of the assays. Results All assays showed robust analytical performance, and particularly P-tau217 Eli Lilly; P-tau231 Gothenburg and all P-tau181 assays showed robust clinical performance to differentiate AD from controls, with AUCs 0.936–0.995 (P-tau231 ADx: AUC = 0.719). Results obtained with all P-tau181 assays, P-tau217 Eli Lilly assay, and P-tau231 Gothenburg assay strongly correlated (Spearman’s rho > 0.86), while correlations with P-tau231 ADx results were moderate (rho < 0.65). Discussion P-tau isoforms can be measured robustly by several novel high-sensitive Simoa assays.
format article
author Sherif Bayoumy
Inge M. W. Verberk
Ben den Dulk
Zulaiga Hussainali
Marissa Zwan
Wiesje M. van der Flier
Nicholas J. Ashton
Henrik Zetterberg
Kaj Blennow
Jeroen Vanbrabant
Erik Stoops
Eugeen Vanmechelen
Jeffrey L. Dage
Charlotte E. Teunissen
author_facet Sherif Bayoumy
Inge M. W. Verberk
Ben den Dulk
Zulaiga Hussainali
Marissa Zwan
Wiesje M. van der Flier
Nicholas J. Ashton
Henrik Zetterberg
Kaj Blennow
Jeroen Vanbrabant
Erik Stoops
Eugeen Vanmechelen
Jeffrey L. Dage
Charlotte E. Teunissen
author_sort Sherif Bayoumy
title Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
title_short Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
title_full Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
title_fullStr Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
title_full_unstemmed Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
title_sort clinical and analytical comparison of six simoa assays for plasma p-tau isoforms p-tau181, p-tau217, and p-tau231
publisher BMC
publishDate 2021
url https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390
work_keys_str_mv AT sherifbayoumy clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT ingemwverberk clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT bendendulk clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT zulaigahussainali clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT marissazwan clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT wiesjemvanderflier clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT nicholasjashton clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT henrikzetterberg clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT kajblennow clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT jeroenvanbrabant clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT erikstoops clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT eugeenvanmechelen clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT jeffreyldage clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
AT charlotteeteunissen clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231
_version_ 1718371973594087424